Our Commitment: Advanced Diagnostics for a Healthier India
A multiple electrolytes injection indicated for fluid replacement, managing haemorrhagic shock, and treating mild to moderate metabolic acidosis. This product’s closed infusion system is designed to meet the critical challenges hospitals face, including infection control and fluid management. At the heart of our operations is the unique 3C approach —Cutting-Edge, Comprehensive, and Conclusive.
Our diagnostics portfolio addresses a wide range of infectious diseases and utilizes AI powered next-generation sequencing (NGS) technology to identify over 35,000 pathogens within 24 hours. This rapid, precise identification helps healthcare professionals prescribe targeted therapies, reducing unnecessary antibiotic use and helping to curb resistance.
A Comprehensive Approach to Diagnostics
With state-of-the-art diagnostic excellence centers located in seven major cities, we serve over 400 hospitals and collaborate with more than 2,500 healthcare professionals. Our diagnostic solutions are not just about speed—they are about accuracy and impact. By reducing turnaround time for conclusive diagnoses, we are saving lives and helping clinicians make informed treatment decisions.
Expanding Access and Impact
As part of our ongoing commitment to India, we expect to expand our diagnostic excellence centers to 25 additional locations by 2025, ensuring more clinicians and patients can access these rapid and life-saving diagnostic services. Through initiatives like the NGAGE CME, NGS CONNECT and partnerships with key opinion leaders, we are also elevating awareness and adoption of advanced diagnostics across the country.
Source:
- World Health Organization: WHO. (2023, November 21). Antimicrobial resistance.